China-based biotech firm Therorna Inc has secured over 280 million yuan (almost $42 million) in a Series A round. Separately, HR tech firm Shebao China has completed a Series C funding round at 270 million yuan ($40.4 million) alongside its rebranding as Yunsheng Group.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
